טוען...
PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab
Background. The primary challenge of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) patient care is the early detection of relapses to prevent organ damage and increase survival. Potential biomarkers for relapses are ANCA and B cells, but their predictive value is a matter o...
שמור ב:
| הוצא לאור ב: | Nephrol Dial Transplant |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8311572/ https://ncbi.nlm.nih.gov/pubmed/32601673 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfaa066 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|